Skip to main content
Clinical Trials/NCT03559088
NCT03559088CompletedNot Applicable

Impact of Integrating a Disease-Specific Migraine App Into the Management of Patients in the Primary Care Setting

Eli Lilly and Company32 sites in 1 country120 target enrollmentStarted: June 11, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
120
Locations
32
Primary Endpoint
Number of Participants Receiving a Preventive Migraine Prescription

Study Overview

Brief Summary

The purpose of this study is to determine whether using a smart phone application to foster communication between study participants and their doctor will impact care. Participants must have a history of migraine or have recently been prescribed a common medicine to treat migraine. The study will last about one year for each participant.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Have a diagnosis of migraine (ICD10: G43.*) since October 2015 OR a record of being prescribed a triptan prior to study
  • Have not been prescribed a preventive migraine medication within the past twelve months
  • Have not visited a neurologist in the past year
  • Have an upcoming visit with their Atrium Health primary care provider

Exclusion Criteria

  • Do not own an iOS or Android smart phone with a data plan or are unwilling to install the app on their phone
  • Are currently participating in a clinical trial involving an investigational drug
  • Have previously used the app used in this study
  • Are pregnant at the time of study entry
  • Are not able to provide informed consent
  • Cannot speak and read English fluently

Outcomes

Primary Outcomes

Number of Participants Receiving a Preventive Migraine Prescription

Time Frame: Next primary care appointment following use of app (estimated as 5 weeks)

Number of Participants Receiving a Preventive Migraine Prescription

Secondary Outcomes

  • Number of Referrals to a Neurologist(Baseline through one year)
  • Number of Participants Receiving Acute and Preventive Migraine Treatments, Opioids, Barbiturates(Baseline through one year)
  • Number of Months of App Use(Baseline through one year)
  • Number of Emergency Room Visits(Baseline through one year)
  • Number of Urgent Care Visits(Baseline through one year)
  • Number of Primary Care Visits(Baseline through one year)
  • Number of Acute Care Visits(Baseline through one year)
  • Number of New Diagnoses of Migraine or Chronic Migraine(Baseline through one year)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (32)

Loading locations...

Similar Trials

A Study of the Effect of a... | Clinical Trial